Department of Cell and Molecular Biology, School of Chemistry, University of Kashan, Kashan, Iran.
Ala Cancer Prevention and Control Center, Isfahan, Iran.
Iran J Med Sci. 2023 Jul;48(4):420-424. doi: 10.30476/IJMS.2022.94539.2587.
Squamous cell carcinoma (SCC) is the most common human solid tumor and the leading cause of cancer death. SCC of the breast is a very rare type of cancer that has not been well researched. Early identification of the genetic factors involved can lead to early diagnosis and targeted treatment. The present study was conducted in 2018 at Isfahan University of Medical Sciences (Isfahan, Iran). The proband was a 66-year-old woman with SCC of the breast and a positive family history of cancer. Blood DNA samples were used for whole-exome sequencing to identify germline pathogenic variants. Variant annotation and prioritization were done on variant call format files using bioinformatics software tools. The screened variants were confirmed using the Sanger sequencing method. Co-segregation analysis was performed on the blood DNA samples of the first- and second-degree relatives of the proband to assess the presence of the mutation. A novel germline pathogenic variant was identified in the gene of the family. is a known protein in DNA repair and replication. Considering its effect on other types of SCC, it may play an important role in SCC initiation and progression in the breast.
鳞状细胞癌(SCC)是最常见的人类实体瘤,也是癌症死亡的主要原因。乳腺 SCC 是一种非常罕见的癌症,尚未得到充分研究。早期识别涉及的遗传因素可导致早期诊断和靶向治疗。本研究于 2018 年在伊朗伊斯法罕医科大学(伊斯法罕)进行。先证者为一名 66 岁女性,患有乳腺 SCC,且有癌症阳性家族史。采集血液 DNA 样本进行全外显子组测序,以鉴定种系致病性变异。使用生物信息学软件工具对变体调用格式文件进行变体注释和优先级排序。使用 Sanger 测序法对先证者一级和二级亲属的血液 DNA 样本进行了筛选变异的确认。在该家族的 基因中发现了一个新的种系致病性变异。 是 DNA 修复和复制中的一种已知蛋白。鉴于其对其他类型 SCC 的影响,它可能在乳腺 SCC 的起始和进展中发挥重要作用。